Filing status
- Accounts due
- 31 January 2028
- Last accounts
- 30 April 2026
- Conf. stmt due
- 9 April 2027
- Last conf. stmt
- 26 March 2026
Fig Therapeutics Limited
- Incorporated
- 16 April 2024 (2 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Giovanni MariggiBenjamin Garfield Perry
- Accounts type
- Small
- Region
- East of England
- Address
- The Cambridge PartnershipDorothy Hodgkin Bldg Babraham Research CampusBabrahamCambridgeCB22 3FH
Officers 3 active
Officer details are public data from the Companies House register.
Mariggi, Giovanni
Director · Appointed 13 May 2024
Italian
Born February 1985 (41)
Perry, Benjamin Garfield
Director · Appointed 13 May 2024
British
Born February 1977 (49)
Corporate Secretary · Appointed 22 April 2024
Officer history (1 former)
13 May 2024
Appointed Mariggi, Giovanni as Director
13 May 2024
Appointed Perry, Benjamin Garfield as Director
13 May 2024
22 April 2024
16 April 2024
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 26 September 2025 | Accounts for a small company | 30 April 2025 | 8 | |
| 15 April 2025 | Confirmation statement with updates | 15 April 2025 | 4 | |
| 22 May 2024 | Cancellation of shares | 6 | ||
| 20 May 2024 | Purchase of own shares | 4 | ||
| 18 May 2024 | Change of share class name or designation | 2 |
Some other companies at this address
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →